Eastwood Bio-Medical Canada Inc.
EWOOF · OTC
10/31/2023 | 10/31/2022 | 10/31/2021 | 10/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -33.2% | 32.5% | 36.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 63.2% | 69.5% | 46.7% | 25% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -47.3% | -2.5% | -50.5% | -103.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -63% | -11.5% | -61.5% | -118.7% |
| EPS Diluted | -0.006 | -0.002 | -0.009 | -0.012 |
| % Growth | -185% | 77.3% | 29% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |